Heltzen Michael's Form 4 filing
Exozymes Inc. (EXOZ) · filed Sep 2, 2026
- Accession no.
- 0001493152-26-041290
- Filed
- Sep 2, 2026, 7:33 PM ET
- Trade date
- Aug 19-26, 2026
- Filing delay
- 14 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market purchases total $6.41K. It was filed 14 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heltzen MichaelCIK 0002030840 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock | PPurchaseAcquired | +4 | $7.58 | +$30.32 | 14,708 | Direct | |
| Aug 26, 2026 | Common Stock | PPurchaseAcquired | +251 | $7.35 | +$1,844.85 | 14,704 | Direct | |
| Aug 26, 2026 | Common Stock | PPurchaseAcquired | +250 | $7.60 | +$1,900 | 14,453 | Direct | |
| Aug 25, 2026 | Common Stock | PPurchaseAcquired | +250 | $7.52 | +$1,880 | 14,203 | Direct | |
| Aug 25, 2026 | Common Stock | PPurchaseAcquired | +100 | $7.50 | +$750 | 13,953 | Direct | |
| Aug 19, 2026 | Common Stock | AGrant or awardAcquired | +8,841 | $6.40 | +$56,582.4 | 13,853 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.